Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | EKF Diagnostics launches ß-Hydroxybutyrate Strip Test at AACC 2013STAT-Site M ß-HB sets standard of care in ketone testing for DKA assessment
By: EKF Diagnostics The presence and degree of ketosis can be rapidly assessed at the point-of-care by accurately measuring blood levels of ß-HB, which accounts for 78% of the three ketone bodies, from just 10 µL of serum or plasma. This provides useful information to provide quality care when monitoring DKA in newly diagnosed patients, whilst also reducing time and costs in an intensive care unit setting [1]. Also at AACC, highlighting the clinical utility of ß-HB for the screening and diagnosis of ketosis, the AACC Industry Workshop ‘Metabolic Disturbances That Lead to ß-Hydroxybutyrate and Ketone Bodies’ will be hosted by EKF on Tuesday July 30, 7–8 am. This will be presented by point-of-care specialist Dr. James Nichols, Professor of Pathology, Microbiology & Immunology and Medical Director of Clinical Chemistry at Vanderbilt University School of Medicine. Attendees will learn about the critical inter-relationships of glucose, diabetes mellitus and conditions that lead to DKA. Early reservation via marketing@stanbio.com is recommended as seating is limited. Booth #3614 will play host to other very recently launched EKF products. These include another strip-based test for the rapid point-of-care analysis of hemoglobin for anemia determination, STAT-Site M Hgb (http://www.ekfdiagnostics.com/ AACC delegates will also have the opportunity to meet the new EKF Molecular Diagnostics (http://www.ekfdiagnostics.com/ Julian Baines, Group CEO, commented, “This year’s AACC Clinical Lab Expo is the first time we have showcased our new EKF Molecular Diagnostics cancer gene detection technology portfolio alongside our clinical chemistry and near-patient testing products. Our experts will be on hand to discuss our ever broadening range of innovative and high-quality IVD diagnostics products. These are designed to rapidly and accurately detect and manage diabetes, anemia, lactate and kidney related diseases, as well as support better informed decisions on patient treatments through companion diagnostics.” Reference: 1) M. Vanelli, G. Chiari, C. Capuano, B. Iovane, A. Bernardini, T. Giacalone. PubMed - October 2003. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|